Medicare Enrolled
Dr. Michael Singer, M.D.
Ophthalmology · San Antonio, TX
Practice pattern: Mixed Practice
— Diverse clinical practice across multiple procedure types
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Singer from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Singer?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Singer
Dr. Michael Singer is an ophthalmology specialist in San Antonio, TX, with 21 years of NPI registration. Based on federal Medicare data, Dr. Singer performed 27,145 Medicare services in 2023. These records do not provide a deduplicated patient total.
Between the years covered by Open Payments, Dr. Singer received a total of $1,715,514 from 47 pharmaceutical and/or device companies across 1547 payment records. A record can group multiple payments. These transfers are publicly reported through CMS Open Payments. Disclosure alone does not establish their effect on care. A reliable breakdown by payment category is not available in this snapshot. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Singer is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 21 years of NPI registration
▲ Top 3% volume in TX
$1,715,514 industry payments
Medicare Practice Summary — 2023
Medicare Utilization ↗27,145
Medicare services
Top 3% in TX for ophthalmology
Not available
Unique patients (not deduplicated)
$56
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Eye injection (Vabysmo/faricimab) An injection of faricimab-svoa, a medication administered in 0.1 mg doses. |
21,533 | $29 | $107 |
| Retinal imaging (OCT scan) This procedure involves imaging the retina to visualize its structure. It is used to examine the back of the eye. |
1,054 | $31 | $150 |
| Eye injection for retinal disease A procedure involving the administration of medication directly into the eye. |
741 | $97 | $360 |
| Comprehensive eye exam, established patient A comprehensive examination of the visual system performed for a patient who has previously been seen by the provider. |
733 | $90 | $150 |
| Tear duct plug insertion A procedure to insert a small plug into the tear duct opening to help retain tears on the eye surface. |
615 | $146 | $466 |
| Aflibercept eye injection (Eylea) | 502 | $683 | $2,000 |
| Extended eye exam with retinal drawing A detailed examination of the back of the eye that includes creating a drawing of the retina. |
450 | $18 | $90 |
| Retinal photography (fundus photo) This procedure involves taking photographs of the retina, the light-sensitive tissue at the back of the eye. It is used to document the condition of the eye's interior structures. |
345 | $28 | $110 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
301 | $70 | $150 |
| Dexamethasone intravitreal implant injection An injection of a dexamethasone implant placed inside the eye. This procedure delivers medication directly into the vitreous cavity of the eye. |
247 | $158 | $430 |
| Injection, ranibizumab, 0.1 mg | 182 | $181 | $700 |
| Eye exam, established patient, focused A limited examination of the visual system for an existing patient. The provider focuses on a specific eye-related concern or symptom. |
159 | $66 | $105 |
| Comprehensive eye exam, new patient A comprehensive examination of the visual system performed for a new patient. |
79 | $92 | $210 |
| Unclassified drug A medication that does not fit into standard HCPCS or CPT classification categories. |
60 | $1,665 | $3,809 |
| Retinal angiography with dye injection This procedure uses a special camera to examine the blood vessels in the retina after a dye has been injected into the body. |
54 | $98 | $200 |
| Visual field test, extended A test that maps your complete field of vision to detect blind spots or peripheral vision loss. Extended testing provides a more detailed assessment than a standard visual field exam. |
26 | $49 | $150 |
| Unclassified biologic A biologic product that does not have a specific HCPCS code assigned. |
24 | $1,939 | $12,396 |
| Retinal laser treatment for leaking blood vessels This procedure uses a laser to seal leaking blood vessels in the retina. It is performed to prevent vision loss caused by fluid leakage from damaged retinal vessels. |
22 | $235 | $1,400 |
| Ultrasound scan of cornea to determine thickness An ultrasound procedure used to measure the thickness of the cornea. |
18 | $8 | $50 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. These counts do not measure clinical quality or years of experience.
Industry Payment Transparency
Open Payments through 2024 ↗$1,715,514
Total received (2018-2024)
Avg $245,073/year across 7 years
Top 0% in TX for ophthalmology
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
47
Companies
1,547
Payment records
Payments are publicly reported; disclosure does not establish legality · Not evidence of wrongdoing · How to interpret →
Payment categories are unavailable while the source breakdown is being rebuilt. Company and year totals do not identify how much belongs to each category.
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$198,483
2023
$302,241
2022
$379,716
2021
$160,040
2020
$90,563
2019
$396,745
2018
$187,726
Payments by company (2024)
Regeneron Healthcare Solutions, Inc.
$68,643
Apellis Pharmaceuticals, Inc.
$38,845
Bausch & Lomb Americas Inc.
$17,866
ABBVIE INC.
$16,187
Alimera Sciences, Inc.
$15,671
Coherus Biosciences Inc.
$13,558
Regeneron Pharmaceuticals, Inc.
$7,816
EyePoint Pharmaceuticals US, Inc.
$4,550
Amgen Inc.
$3,956
Genentech USA, Inc.
$3,712
Harrow Eye, LLC
$3,181
Astellas Pharma US Inc
$2,216
Ocular Therapeutix, Inc.
$2,126
BIOTISSUE HOLDINGS INC.
$134
TearLab Corp
$23
Top 3 companies account for 63.2% of 2024 payments
All-time payments by company (2018-2024) ›
Regeneron Healthcare Solutions, Inc.
$378,489
Genentech USA, Inc.
$168,558
Allergan Inc.
$149,653
EyePoint Pharmaceuticals US, Inc.
$139,291
Novartis Pharmaceuticals Corporation
$133,203
Apellis Pharmaceuticals, Inc.
$132,828
F. Hoffmann-La Roche AG
$73,528
Coherus Biosciences Inc.
$69,346
Bausch & Lomb Americas Inc.
$65,359
Biogen, Inc.
$60,878
Alimera Sciences, Inc.
$57,769
Astellas Pharma US Inc
$44,987
Allergan, Inc.
$44,391
ABBVIE INC.
$34,374
Novartis Pharma AG
$25,800
Spark Therapeutics, Inc.
$23,471
AbbVie Inc.
$18,649
Genentech, Inc.
$17,681
Regeneron Pharmaceuticals, Inc.
$16,878
Mallinckrodt LLC
$12,550
Ocular Therapeutix, Inc.
$10,465
Aerie Pharmaceuticals, Inc.
$7,568
NOVARTIS PHARMACEUTICALS CORPORATION
$4,300
Amgen Inc.
$3,956
Harrow Eye, LLC
$3,206
Roche Products Limited
$3,150
Alcon Vision LLC
$2,850
Bausch & Lomb, a division of Bausch Health US, LLC
$2,680
Oyster Point Pharma, Inc.
$2,157
Roche TCRC, Inc.
$2,118
Vertex Pharmaceuticals Incorporated
$1,833
TISSUETECH, INC.
$1,543
Dr.Reddy's Laboratories,Inc.
$738
TissueTech, Inc.
$237
BIOTISSUE HOLDINGS, INC.
$188
Mallinckrodt Hospital Products Inc.
$176
BIOTISSUE HOLDINGS INC.
$134
TOPCON MEDICAL SYSTEMS, INC.
$125
Mallinckrodt Enterprises LLC
$122
OPTOS, INC.
$97
Carl Zeiss Meditec, Inc.
$62
ThromboGenics, Inc.
$33
TearLab Corp
$23
Optos, Inc.
$22
Carl Zeiss Meditec AG
$19
Mission Pharmacal Company
$18
Avedro Inc.
$9
Top 3 companies account for 40.6% of all-time payments
Associated products mentioned in payments ›
ACTHAR · AcrySof IQ PanOptix · BEOVU · BOTOX COSMETIC · BROLUCIZUMAB · CIRRUS HD-OCT · COMBIGAN · Cimerli · Clareon · DEXTENZA · DEXYCU · DOCTORS ALLERGY FORMULA · DURYSTA · EYLEA · EYLEA AFLIBERCEPT INJECTION · EYLEA HD · EYP-1901 · Empaveli · IHEEZO · ILUVIEN · Iluvien · Izervay · Jetrea · LUMAKRAS · LUXTURNA · Lucentis · MIEBO · Monaco · Non-Covered Product · None Specified · OCT TRITON · ORA · OZURDEX · PANORAMIC OPHTHALMOSCOPE · PROKERA · PanOptix · Photrexa · Prokera · RETISERT · RTH258A · Rocklatan · SIMBRINZA · SUSVIMO · ScoutPro Osmolarity System · Simbrinza · Susvimo · Syfovre · TEPEZZA · TRAVATAN Z · TYRVAYA · Udenyca · VABYSMO · VISUDYNE · VYZULTA · Vabysmo · XIIDRA · XIPERE · YUTIQ
Should you be concerned? Industry payments are disclosed through CMS Open Payments. Disclosure alone does not establish their purpose, legality, or effect on care. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Geographic Context
Ophthalmologists in nearby ZIP areas
164
County median income
$70,571
Nearest hospital to ZIP centroid (approximate)
SAN ANTONIO BEHAVIORAL HEALTHCARE HOSPITAL
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | NPPES snapshot; verify current record |
| Medicare Enrollment | ✓ PECOS | PECOS snapshot |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not included | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Singer is a mixed practice specialist, with above-average Medicare volume (top 3% in TX), with 21 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Singer experienced with eye injection (vabysmo/faricimab)?
Based on Medicare claims data, Dr. Singer performed 21,533 eye injection (vabysmo/faricimab) services. These records cover Medicare fee-for-service activity, including eligible younger beneficiaries; they do not measure total practice volume or clinical quality.
Does Dr. Singer receive payments from pharmaceutical companies?
Yes. Dr. Singer received a total of $1,715,514 from 47 companies across 1,547 payment records. A record can group multiple payments. These transfers are publicly disclosed through CMS Open Payments. Disclosure alone does not establish their legality or effect on care. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Singer's costs compare to other ophthalmologists in San Antonio?
Dr. Singer's average Medicare payment per service is $56. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Singer) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating the presence of registry, enrollment, activity or payment records, not verified experience or clinical quality. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Source publication dates and the snapshots loaded on this site can differ. Rebuilding a page does not refresh its source records. Check the Medicare reporting year and the payment interval shown above; consult the linked official sources for newer releases and current registry details. See our data freshness policy →
Explore related providers
Same specialty & city
Ophthalmologists in San Antonio
Browse ophthalmologists in San Antonio ranked by procedure volume and transparency data.
Highest volume
Top Ophthalmologists in TX
Ophthalmologists ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Ophthalmologists in TX
Which TX ophthalmologists receive the most from drug and device companies.
By company
Regeneron Healthcare Solutions, Inc. Payments to Doctors
See all physicians who received payments from Regeneron Healthcare Solutions, Inc.
By company
Genentech USA, Inc. Payments to Doctors
See all physicians who received payments from Genentech USA, Inc.
By company
Allergan Inc. Payments to Doctors
See all physicians who received payments from Allergan Inc.
About this page
This page combines public CMS records with calculated summaries and explanatory procedure labels. These transformations are not verbatim federal records. Sources: NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology